Maker of Ozempic, Wegovy to build massive facility in North Carolina

The transcript discusses the strength of Ozempic, highlighting the construction of a new $4.1 billion plant in North Carolina by Novo Nordisk. This facility is expected to create 1000 jobs and open after 2027. It will produce current and future injectable treatments for obesity and other chronic diseases, showcasing the company's commitment to addressing serious health issues.

What types of treatments will the new facility produce?

What are some of the chronic diseases that the treatments from the new plant will address?